| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Punt Blocking Peptide for STJ502734 is synthetically produced from the 497-515 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen Region: | 497-515 |
| Specificity: | This blocking peptide is recommended for use in combination with Punt antibody, STJ502734 |
| Immunogen: | Synthetic peptide corresponding to C terminal amino acids 497-515 of Drosophila melanogaster PUNT protein. Peptides were amidated for conjugation. Sequence: QLLIKNHTNIDDAKESTNCSynthetic peptide corresponding to C terminal amino acids 497-515 of Droso |
| Background | ATP + [receptor-protein] = ADP + [receptor-protein] phosphate. |
Information sourced from Uniprot.org